King Pharmaceuticals, Inc. KG

SEC CIK	1047699
Domicile	TN

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Inside Counsel (5)

Go Pro to view corporate inside counsel.

Outside Counsel (130)

	Last Name	First Name	Middle Name	Firm	Location
	Safir	Peter	Oliver	Covington & Burling, LLP	Washington, DC
	Scerra	Louis	J.	Greenberg Traurig, LLP	BOSTON, MA
	Schmidt	Lisa	A.	Richards, Layton & Finger, PA
	Schmitt	David	J.	Lamson, Dugan and Murray, LLP	Omaha, NE
	Schroth	Kevin	R.j.	Cole, Schotz, Meisel, Forman & Leonard, PA	New York, NY
	Servodidio.	Gianni	P.	Jenner & Block, LLP
	Shadmand	Sheila	L.	Jones Day Reavis & Pogue
	Shih	Evangeline		Jones Day Reavis & Pogue
	Short	Jonathan	M	McCarter & English LLP	Newark, NJ
	Slater	Thomas	G.	Hunton & Williams LLP	Richmond, VA
	Smith	Rodger	Dallery	Morris, Nichols, Arsht & Tunnell LLP	Wilmington, DE
	Smith	Scott		Buchalter Nemer Fields & Younger, APC	Los Angeles, CA
	Solow	Andrew	K	Arnold & Porter, LLP	New York, NY
	Starnes	John	Barrett	Baker Donelson Bearman Caldwell & Berkowitz,...	Memphis, TN
	Stenglein	Mike		King & Spalding LLP	Austin , TX
	Stops	Eric	C.	Pennie & Edmonds LLP	New York, NY
	Swisher	Kathryn		White & Case LLP	New York, NY
	Tate	Rodger	L.	Hunton & Williams LLP	Washington, DC
	Terrell	Allen	M	Terrell, Allen M
	Thomas	David	M.	Dinsmore & Shohl LLP	Morgantown, WV
	Thrasher	Edward		White & Case LLP	New York, NY
	Toberts	Jon	L.	Roberts Abokhair & Mardula LLC	RESTON, VA
	Trefil	James	Karel	Hogan & Hartson, LLP
	Tucker	Douglas	Allen	Kaye Scholer LLP	Washington, DC
	Valentina	Elizabeth		Jenner & Block, LLP	New York, NY
	Vant	James	M.	Greenberg Traurig, LLP
	Wagner	Jeffrey		Arnold & Porter, LLP	Chicago, IL
	Woodard	Brendan	G.	White & Case LLP
	Yates	Pamela	Joan	Arnold & Porter, LLP
	Zoubek	Nancy		rlscf.com Law Firm Placeholder	New York, NY

130 Rows Total	Page 2 of 2 | Go To

Filter By Form All Records 10-K 10-K/A 10-Q 10-Q/A 11-K 15-12B 25 3 4 4/A 424B3 424B4 424B5 424B7 425 5 5/A 8-A12B 8-A12B/A 8-A12G 8-K 8-K/A ARS CORRESP CT ORDER DEF 14A DEFA14A DFAN14A EFFECT NO ACT NT 10-K NT 10-Q POS AM POSASR PRE 14A PRER14A S-1 S-1/A S-3 S-3/A S-3ASR S-4 S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SC 14D9 SC 14D9/A SC TO-C SC TO-I SC TO-I/A SC TO-T SC TO-T/A SC14D9C UPLOAD From To

	Date	Entity	Form Number	Description
	3/11/2011		NO ACT
	3/11/2011		NO ACT
	3/1/2011		SC TO-I/A
	3/1/2011		4	Statement of changes in beneficial ownership of securities
	3/1/2011		4	Statement of changes in beneficial ownership of securities
	3/1/2011		4	Statement of changes in beneficial ownership of securities
	3/1/2011		4	Statement of changes in beneficial ownership of securities
	3/1/2011		4	Statement of changes in beneficial ownership of securities
	3/1/2011		4	Statement of changes in beneficial ownership of securities
	3/1/2011		4	Statement of changes in beneficial ownership of securities
	3/1/2011		4	Statement of changes in beneficial ownership of securities
	3/1/2011		4	Statement of changes in beneficial ownership of securities
	3/1/2011		15-12B
	2/23/2011		UPLOAD
	2/23/2011		S-8 POS
	2/23/2011		S-8 POS
	2/23/2011		S-8 POS
	2/23/2011		S-8 POS
	2/23/2011		S-8 POS
	2/23/2011		S-8 POS
	2/23/2011		S-8 POS
	2/23/2011		EFFECT
	2/23/2011		EFFECT
	2/23/2011		EFFECT
	2/22/2011		8-K	Current report pursuant to Section 13 or 15(d)
	2/18/2011		POSASR
	2/18/2011		POSASR
	2/18/2011		POS AM
	2/18/2011		POS AM
	2/18/2011		POS AM
	2/18/2011		25
	2/15/2011		SC 13G
	2/15/2011		4	Statement of changes in beneficial ownership of securities
	2/14/2011		SC 13G
	2/14/2011		SC 13G/A
	2/10/2011		SC 13G/A
	2/10/2011		SC 13D
	2/9/2011		3	Initial statement of beneficial ownership of securities
	2/9/2011		3	Initial statement of beneficial ownership of securities
	2/9/2011		3	Initial statement of beneficial ownership of securities
	2/9/2011		3	Initial statement of beneficial ownership of securities
	2/9/2011	Pfizer, Inc.	3	Initial statement of beneficial ownership of securities
	2/9/2011		3	Initial statement of beneficial ownership of securities
	2/8/2011		8-K	Current report pursuant to Section 13 or 15(d)
	2/7/2011		SC 13G/A
	2/4/2011		8-K	Current report pursuant to Section 13 or 15(d)
	2/2/2011		4	Statement of changes in beneficial ownership of securities
	2/2/2011		4	Statement of changes in beneficial ownership of securities
	2/2/2011		4	Statement of changes in beneficial ownership of securities
	2/2/2011		4	Statement of changes in beneficial ownership of securities

851 Rows Total	Page 1 of 18 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	2/4/2011	Credit Suisse Ag	Assignor	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 109 more	07560004 07643244 08188745 07711719 06451891 08012109 08072204 08057516 07871376 07250300 07335443 07296513 08396948 07744857 08877752 07122380 08025301 07214457 09440330 07564618 07357822 07598527 07770676 08077305 08194634 08428613 07023277 ...and 109 more	Azetidinone Intermediates To Carbacephalosporins And Process Stabilized Medicinal Substances, A Process For The Preparation Thereof, ... Intermediates To 1-carbacephalosporins And Process For Preparation There... Process And Intermediates For Chiral Epoxides Ring-closure Method For 1-carbacephalosporin Six-membered Ring Cis, Endo-2-azabicycloalkane-3-carboxylic Acid Derivatives Method For The Treatment Of Atherosclerosis, Thrombosis, And Peripheral ... Process For The Preparation Of N-alkylated Dipeptides And Their Esters Amino Protecting Group Process Of Preparing Proline Derivatives Identification Test For Highly Refined Sesame Oil Novel 4-(2,3 Epoxy Propane) Azetidinones Process For Preparing Loracarbef Monohydrate Cis, Endo-2-azabicyclo-(3.3.0)-octane-3-carboxylic Acids, A Process For ... Intermediates For Preparing Mono-,bi-and Tricyclic Amino Acids Angiotensin-converting Enzyme Inhibitors New Amino Protecting Group Process For The Resolution Of Racemates Of Optically Active Bicyclic Imi... Enantiomerically Selective Biocatalyzed Acylation Monohydrate And Dmf Solvates Of A New Carbacephem Antibiotic Process For Preparing Crystalline Beta-lactam Monohydrate Angiotensin-coverting Enzyme Inhibitors Disubstituted Proline Derivatives, Pharmaceutical Composition For The Treatment Of High Blood Pressure Process For The Preparation Of N Octahydropenta (b) Pyrrole Carboxylates Bicyclic Beta-lactam Antibiotics Use Of A Combination Of Angiotensin-converting Enzyme Inhibitor And Calc... ...and 109 more
	2/3/2011	Credit Suisse Ag	Assignor	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 33 more	08012109 08071550 07095721 08025301 07601021 07530140 07591586 07770676 08347759 08428613 07750214 07588381 08077305 07735747 07691257 07324169 08071552 07734394 07881913 08396948 08464480 07918196 07871376 08444124 07889221 07744857 07518384 ...and 33 more	Azetidinone Intermediates To Carbacephalosporins And Process Loracarbef Isopropanolate And A Process For Converting Loracarbef Isopro... Process And Intermediates For Chiral Epoxides Novel 4-(2,3 Epoxy Propane) Azetidinones Enantiomerically Selective Biocatalyzed Acylation Dmf Solvates Of A Beta-lactam Antibiotic Monohydrate And Dmf Solvates Of A New Carbacephem Antibiotic Amino Protecting Group Intermediates To 1-carbacephalosporins And Process For Preparation There... Loracarbef Hydrochloride C1-c3 Alcohol Solvates And Uses Thereof Bicyclic Beta-lactam Antibiotics New Amino Protecting Group 1-carba(dethia)-3-hydroxy-3-cephem Ester Crystalline And Crystalline Sol... Process For Converting Loracarbef Dihydrate To Loracarbef Monohydrate Process And Intermediates For Chiral Epoxides Azetidinone Intermediates To Carbacephalosporins And Process Process For Preparing Loracarbef Monohydrate Process And Intermediates For Chiral Epoxides Azetidinone Intermediates To Carbacephalosporins And Process Loracarbef Isopropanolate And A Process For Converting Loracarbef Isopro... Process And Intermediates For Chiral Epoxides Novel 4-(2,3 Epoxy Propane) Azetidinones Process Of Enantiomeric Separation Of Carbacephem Intermediates Process For Preparing Crystalline Beta-lactam Monohydrate Photochemical Conversion Of Cephalosporins, 1-carba(1-dethia) Cephalospo... Ring-closure Method For 1-carbacephalosporin Six-membered Ring Intermediates To 1-carbacephalosporins And Process For Preparation There... ...and 33 more
	2/2/2011	Credit Suisse Ag	Assignor	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 29 more	07771795 07588381 07750214 08072204 07889221 07643244 08104383 08012109 07735747 11927918 08916578 07871376 07591586 08077305 07918196 07691257 08396948 08071550 07744857 12455571 08025301 07881913 07598527 08082804 08071552 07734394 08444124 ...and 29 more	Loracarbef Hydrochloride C1-c3 Alcohol Solvates And Uses Thereof Process Of Enantiomeric Separation Of Carbacephem Intermediates Process For Preparing Crystalline Beta-lactam Monohydrate Azetidinone Intermediates To Carbacephalosporins And Process 3-thiazolylthio Carbacephem Antibacterial Agents Intermediates To 1-carbacephalosporins And Process For Preparation There... Pharmaceutical Compositions Process For Preparing 4-substituted Azetidinones Process And Intermediates For Chiral Epoxides Loracarbef Isopropanolate And A Process For Converting Loracarbef Isopro... New Amino Protecting Group Beta-lactam Antibiotics Pharmaceutical Composition Amino Protecting Group Oxygen-impervious packaging with optional oxygen scavenger, stabilized t... Novel 4-(2,3 Epoxy Propane) Azetidinones Process For Converting Loracarbef Dihydrate To Loracarbef Monohydrate Loracarbef Hydrochloride C1-c3 Alcohol Solvates And Uses Thereof Process Of Enantiomeric Separation Of Carbacephem Intermediates Process For Preparing Crystalline Beta-lactam Monohydrate Process For Preparing Loracarbef Monohydrate Ring-closure Method For 1-carbacephalosporin Six-membered Ring New Amino Protecting Group Pharmaceutical Compositions Process For Preparing 4-substituted Azetidinones Process And Intermediates For Chiral Epoxides Loracarbef Hydrochloride C1-c3 Alcohol Solvates And Uses Thereof ...and 29 more
	5/14/2010	Credit Suisse Ag	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 29 more	12455571 08072204 07744857 07750214 08104383 07881913 07598527 08916578 08012109 07734394 08071552 08077305 07771795 07588381 08396948 07889221 07643244 11927918 08071550 07735747 08025301 08082804 07871376 07591586 08444124 07918196 07691257 ...and 29 more	Ring-closure Method For 1-carbacephalosporin Six-membered Ring New Amino Protecting Group Loracarbef Hydrochloride C1-c3 Alcohol Solvates And Uses Thereof Process For Preparing 4-substituted Azetidinones Process And Intermediates For Chiral Epoxides Azetidinone Intermediates To Carbacephalosporins And Process New Amino Protecting Group Enantiomerically Selective Biocatalyzed Acylation Bicyclic Beta-lactam Antibiotics Pharmaceutical Compositions Amino Protecting Group Novel 4-(2,3 Epoxy Propane) Azetidinones Loracarbef Isopropanolate And A Process For Converting Loracarbef Isopro... Oxygen-impervious packaging with optional oxygen scavenger, stabilized t... Intermediates To 1-carbacephalosporins And Process For Preparation There... Process For Converting Loracarbef Dihydrate To Loracarbef Monohydrate Thrombin Purification Ring-closure Method For 1-carbacephalosporin Six-membered Ring New Amino Protecting Group Loracarbef Hydrochloride C1-c3 Alcohol Solvates And Uses Thereof 3-thiazolylthio Carbacephem Antibacterial Agents Intermediates To 1-carbacephalosporins And Process For Preparation There... Process For Preparing Loracarbef Monohydrate Enantiomerically Selective Biocatalyzed Acylation Bicyclic Beta-lactam Antibiotics Pharmaceutical Compositions Amino Protecting Group ...and 29 more
	5/11/2010	Credit Suisse Ag	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 41 more	07588381 07591586 08444124 07881913 07770676 07601021 08916578 08071550 07918196 07744857 11927918 08104383 07735747 07643244 08396948 08012109 07889221 07518384 10360208 08025301 08072204 07734394 07324169 08077305 07771795 07750214 07691257 ...and 41 more	Pharmaceutical Compositions Thrombin purification Process For Preparing 4-substituted Azetidinones Bicyclic Beta-lactam Antibiotics Process For Converting Loracarbef Dihydrate To Loracarbef Monohydrate Pharmaceutical Compositions Monohydrate And Dmf Solvates Of A New Carbacephem Antibiotic Process And Intermediates For Chiral Epoxides Process For Preparing Crystalline Beta-lactam Monohydrate Identification Test For Highly Refined Sesame Oil Ring-closure Method For 1-carbacephalosporin Six-membered Ring New Amino Protecting Group Process And Intermediates For Chiral Epoxides Loracarbef Hydrochloride C1-c3 Alcohol Solvates And Uses Thereof Enantiomerically Selective Biocatalyzed Acylation Beta-lactam Antibiotics Pharmaceutical Composition Loracarbef Hydrochloride C1-c3 Alcohol Solvates And Uses Thereof Photochemical Conversion Of Cephalosporins, 1-carba(1-dethia) Cephalospo... Process Of Enantiomeric Separation Of Carbacephem Intermediates Pharmaceutical Compositions Thrombin purification Process For Preparing 4-substituted Azetidinones Bicyclic Beta-lactam Antibiotics Loracarbef Isopropanolate And A Process For Converting Loracarbef Isopro... Amino Protecting Group Oral trimethobenzamide formulations and methods ...and 41 more
	12/30/2008	Credit Suisse	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 41 more	08104383 07771795 07734394 07324169 08396948 08012109 07750214 07691257 08072204 07871376 07598527 11440678 08077305 07881913 07588381 07591586 08877752 08071552 07770676 07601021 08082804 07918196 07744857 11927918 08444124 08025301 07735747 ...and 41 more	Oral trimethobenzamide formulations and methods Process And Intermediates For Chiral Epoxides Intermediates To 1-carbacephalosporins And Process For Preparation There... Process For Converting Loracarbef Dihydrate To Loracarbef Monohydrate Pharmaceutical Compositions Ring-closure Method For 1-carbacephalosporin Six-membered Ring New Amino Protecting Group Process And Intermediates For Chiral Epoxides Process For Preparing Loracarbef Monohydrate 3-thiazolylthio Carbacephem Antibacterial Agents Intermediates To 1-carbacephalosporins And Process For Preparation There... Amino Protecting Group Loracarbef Hydrochloride C1-c3 Alcohol Solvates And Uses Thereof Photochemical Conversion Of Cephalosporins, 1-carba(1-dethia) Cephalospo... Process Of Enantiomeric Separation Of Carbacephem Intermediates Pharmaceutical Composition Azetidinone Intermediates To Carbacephalosporins And Process Thrombin Purification Novel 4-(2,3 Epoxy Propane) Azetidinones New Amino Protecting Group Pharmaceutical Compositions Oral trimethobenzamide formulations and methods Process And Intermediates For Chiral Epoxides Intermediates To 1-carbacephalosporins And Process For Preparation There... Process For Converting Loracarbef Dihydrate To Loracarbef Monohydrate Pharmaceutical Compositions Monohydrate And Dmf Solvates Of A New Carbacephem Antibiotic ...and 41 more
	3/29/2007	Duramed Pharmaceuticals, Inc.	Assignee	Application Publication Patent	10134455 20020165209 6747019	Low Dose Estrogen Interrupted Hormone Replacement Therapy Low Dose Estrogen Interrupted Hormone Replacement Therapy Low Dose Estrogen Interrupted Hormone Replacement Therapy
	3/29/2007	Duramed Pharmaceuticals, Inc.	Assignee	Application Publication Patent	11439171 20060211663 7320970	Low Dose Estrogen Interrupted Hormone Replacement Therapy Low Dose Estrogen Interrupted Hormone Replacement Therapy Low Dose Estrogen Interrupted Hormone Replacement Therapy
	3/29/2007	Ortho-mcneil Pharmaceutical Inc.	Assignor	Application Publication Patent	11439171 20060211663 7320970	Low Dose Estrogen Interrupted Hormone Replacement Therapy Low Dose Estrogen Interrupted Hormone Replacement Therapy Low Dose Estrogen Interrupted Hormone Replacement Therapy
	7/31/2006	Pawlak, Dan	Assignor	Application Publication	11440678 20060270015	Thrombin purification Thrombin purification
	7/31/2006	Chesmore, Gerald	Assignor	Application Publication	11440678 20060270015	Thrombin purification Thrombin purification
	7/31/2006	Knoll, Bradley H.	Assignor	Application Publication	11440678 20060270015	Thrombin purification Thrombin purification
	7/31/2006	Terrab, Abdel Hak	Assignor	Application Publication	11440678 20060270015	Thrombin purification Thrombin purification
	7/31/2006	Irwin, J. Foster	Assignor	Application Publication	11440678 20060270015	Thrombin purification Thrombin purification
	12/28/2005	Ortho-mcneil Pharmaceutical, Inc.	Assignor	Application Publication Patent	10806613 20040180867 7078394	Low Dose Estrogen Interrupted Hormone Replacement Therapy Low Dose Estrogen Interrupted Hormone Replacement Therapy Low Dose Estrogen Interrupted Hormone Replacement Therapy
	12/28/2005	Duramed Pharmaceuticals, Inc.	Assignee	Application Publication Patent	10806613 20040180867 7078394	Low Dose Estrogen Interrupted Hormone Replacement Therapy Low Dose Estrogen Interrupted Hormone Replacement Therapy Low Dose Estrogen Interrupted Hormone Replacement Therapy
	9/29/2005	Credit Suisse	Assignor	Application Patent	08702350 5733151	Electrical Clamping Connection Device Electrical Clamping Connection Device
	10/29/2004	Ortho-mcneil Pharmaceutical, Inc.	Assignor	Application Application Publication Publication Patent Patent	10806613 10134455 20040180867 20020165209 7078394 6747019	Low Dose Estrogen Interrupted Hormone Replacement Therapy Low Dose Estrogen Interrupted Hormone Replacement Therapy Low Dose Estrogen Interrupted Hormone Replacement Therapy Low Dose Estrogen Interrupted Hormone Replacement Therapy Low Dose Estrogen Interrupted Hormone Replacement Therapy Low Dose Estrogen Interrupted Hormone Replacement Therapy
	3/5/2004	Fisons Ltd.	Assignor	Application Patent	06720588 4760072	Soild Nedocromil Sodium, Useful As For The Remval Of Obstructed Air Path... Soild Nedocromil Sodium, Useful As For The Remval Of Obstructed Air Pat...
	3/5/2004	Fisons Ltd.	Assignor	Application Patent	08082804 5443833	Pharmaceutical Compositions Pharmaceutical Compositions
	3/5/2004	Fisons Ltd.	Assignor	Application Patent	06344982 4474787	7,6 Dioxo-4h,6h-pyrano[3,2q]quinoline Dicarboxylic Acids And Anti- Aller... 7,6 Dioxo-4h,6h-pyrano[3,2q]quinoline Dicarboxylic Acids And Anti- Aller...
	3/5/2004	Fisons Ltd.	Assignor	Application Patent	07771795 5248493	Pharmaceutical Composition Pharmaceutical Composition
	3/5/2004	Fisons Ltd.	Assignor	Application Patent	07727322 5260306	Inhalation Pharmaceuticals Inhalation Pharmaceuticals
	3/5/2004	Fisons Ltd.	Assignor	Application Patent	07109049 4918078	Pharmaceutical Compositions Containing Nedocromil Sodium Pharmaceutical Compositions Containing Nedocromil Sodium
	3/5/2004	Fisons Ltd.	Assignor	Application Patent	06606542 4590206	Inhalation Pharmaceuticals Inhalation Pharmaceuticals
	3/5/2004	Fisons Ltd.	Assignor	Application Patent	08916578 RE38628	Pharmaceutical Compositions Pharmaceutical Compositions
	10/2/2002	Credit Suisse First Boston	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 41 more	07598527 07770676 08077305 08428613 09440330 08071550 08347759 07530140 07750214 07734394 07324169 07735747 08104383 07881913 08444124 07588381 07095721 08071552 07601021 07591586 07918196 07691257 07518384 07889221 08464480 08012109 08072204 ...and 41 more	Azetidinone Intermediates To Carbacephalosporins And Process Intermediates To 1-carbacephalosporins And Process For Preparation There... Photochemical Conversion Of Cephalosporins, 1-carba(1-dethia) Cephalospo... Process Of Enantiomeric Separation Of Carbacephem Intermediates Amino Protecting Group Identification Test For Highly Refined Sesame Oil Novel 4-(2,3 Epoxy Propane) Azetidinones Process For Preparing Loracarbef Monohydrate New Amino Protecting Group Dmf Solvates Of A Beta-lactam Antibiotic Loracarbef Isopropanolate Process For Converting Loracarbef Dihydrate To Loracarbef Monohydrate 3-thiazolylthio Carbacephem Antibacterial Agents Bicyclic Beta-lactam Antibiotics Loracarbef Isopropanolate And A Process For Converting Loracarbef Isopro... Process And Intermediates For Chiral Epoxides Diagnostic Uses Of 2-substituted Adenosine Carboxamides Azetidinone Intermediates To Carbacephalosporins And Process Loracarbef Hydrochloride C1-c3 Alcohol Solvates And Uses Thereof Process And Intermediates For Chiral Epoxides Process For Preparing 4-substituted Azetidinones Azetidinone Intermediates To Carbacephalosporins And Process Intermediates To 1-carbacephalosporins And Process For Preparation There... Process And Intermediates For Chiral Epoxides Ring-closure Method For 1-carbacephalosporin Six-membered Ring Amino Protecting Group Identification Test For Highly Refined Sesame Oil ...and 41 more
	11/28/2001	Chen, Shih-feng	Assignor	Application Patent	09377271 6326390	The Use Of Adenosine A3 Receptor Antagonists To Inhibit Tumor Growth The Use Of Adenosine A3 Receptor Antagonists To Inhibit Tumor Growth
	11/28/2001	Leung, Edward	Assignor	Application Patent	09377271 6326390	The Use Of Adenosine A3 Receptor Antagonists To Inhibit Tumor Growth The Use Of Adenosine A3 Receptor Antagonists To Inhibit Tumor Growth
	9/19/2001	Credit Suisse First Boston	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 33 more	07770676 08347759 08428613 07735747 07750214 07588381 08077305 07734394 07691257 07324169 08071552 07881913 08396948 08464480 07889221 07918196 07871376 08444124 08104383 07744857 07518384 08072204 08012109 08071550 07095721 07591586 08025301 ...and 33 more	Process For Preparing Crystalline Beta-lactam Monohydrate Photochemical Conversion Of Cephalosporins, 1-carba(1-dethia) Cephalospo... Ring-closure Method For 1-carbacephalosporin Six-membered Ring Process Of Enantiomeric Separation Of Carbacephem Intermediates Dmf Solvates Of A Beta-lactam Antibiotic Monohydrate And Dmf Solvates Of A New Carbacephem Antibiotic Amino Protecting Group Enantiomerically Selective Biocatalyzed Acylation Loracarbef Hydrochloride C1-c3 Alcohol Solvates And Uses Thereof Beta-lactam Antibiotics New Amino Protecting Group Intermediates To 1-carbacephalosporins And Process For Preparation There... 1-carba(dethia)-3-hydroxy-3-cephem Ester Crystalline And Crystalline Sol... Process For Converting Loracarbef Dihydrate To Loracarbef Monohydrate Process And Intermediates For Chiral Epoxides Azetidinone Intermediates To Carbacephalosporins And Process Loracarbef Isopropanolate Process And Intermediates For Chiral Epoxides Loracarbef Isopropanolate And A Process For Converting Loracarbef Isopro... Process And Intermediates For Chiral Epoxides Novel 4-(2,3 Epoxy Propane) Azetidinones Azetidinone Intermediates To Carbacephalosporins And Process Dmf Solvates Of A Beta-lactam Antibiotic Monohydrate And Dmf Solvates Of A New Carbacephem Antibiotic Amino Protecting Group Enantiomerically Selective Biocatalyzed Acylation Loracarbef Hydrochloride C1-c3 Alcohol Solvates And Uses Thereof ...and 33 more
	6/13/2001	Baraldi, Pier Giovanni	Assignor	Application Patent	09377271 6326390	The Use Of Adenosine A3 Receptor Antagonists To Inhibit Tumor Growth The Use Of Adenosine A3 Receptor Antagonists To Inhibit Tumor Growth
	6/13/2001	Borea, Pier Andrea	Assignor	Application Patent	09377271 6326390	The Use Of Adenosine A3 Receptor Antagonists To Inhibit Tumor Growth The Use Of Adenosine A3 Receptor Antagonists To Inhibit Tumor Growth
	12/11/2000	Ternansky, Robert J.	Assignor	Application Patent	07643244 5077287	3-thiazolylthio Carbacephem Antibacterial Agents 3-thiazolylthio Carbacephem Antibacterial Agents
	2/9/2000	Eli Lilly And Company	Assignor	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 33 more	08072204 07889221 07591586 08444124 07881913 07518384 07734394 08428613 08071552 07750214 07324169 08104383 07871376 07691257 08396948 08025301 07744857 07735747 08071550 07770676 07530140 08347759 08077305 07918196 07601021 08464480 08012109 ...and 33 more	Azetidinone Intermediates To Carbacephalosporins And Process Photochemical Conversion Of Cephalosporins, 1-carba(1-dethia) Cephalospo... New Amino Protecting Group Process For Preparing Crystalline Beta-lactam Monohydrate 1-carba(dethia)-3-hydroxy-3-cephem Ester Crystalline And Crystalline Sol... Beta-lactam Antibiotics Process And Intermediates For Chiral Epoxides Azetidinone Intermediates To Carbacephalosporins And Process Process Of Enantiomeric Separation Of Carbacephem Intermediates Process And Intermediates For Chiral Epoxides Process And Intermediates For Chiral Epoxides Loracarbef Hydrochloride C1-c3 Alcohol Solvates And Uses Thereof Monohydrate And Dmf Solvates Of A New Carbacephem Antibiotic New Amino Protecting Group Loracarbef Hydrochloride C1-c3 Alcohol Solvates And Uses Thereof Enantiomerically Selective Biocatalyzed Acylation Intermediates To 1-carbacephalosporins And Process For Preparation There... Loracarbef Isopropanolate And A Process For Converting Loracarbef Isopro... Loracarbef Isopropanolate Dmf Solvates Of A Beta-lactam Antibiotic Process And Intermediates For Chiral Epoxides Process For Converting Loracarbef Dihydrate To Loracarbef Monohydrate 1-carba(dethia)-3-hydroxy-3-cephem Ester Crystalline And Crystalline Sol... Beta-lactam Antibiotics Process And Intermediates For Chiral Epoxides Azetidinone Intermediates To Carbacephalosporins And Process Intermediates To 1-carbacephalosporins And Process For Preparation There... ...and 33 more
	10/21/1999	Eli Lilly And Company	Assignor	Application Patent	07598527 5106475	Process For Preparing 4-substituted Azetidinones Process For Preparing 4-substituted Azetidinones
	3/11/1999	Credit Suisse First Boston	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application Application ...and 39 more	08202478 07678187 07214457 06568423 07798501 07296513 07122380 08877752 08188745 07274598 07357822 06681329 07564618 07318519 06658902 08930562 07979390 07560004 07127953 06604220 08194634 07562402 07335443 06575401 07711719 07173024 07023277 ...and 39 more	Method Of Resolving Bicyclic Imino-alpha-carboxylic Acid Ester Racemates Combination Of Angiotensin Converting Enzyme Inhibitors With Potassium C... Stabilized Medicinal Substances, A Process For The Preparation Thereof, ... Method Of Treating Cardiac Insufficiency Using Angiotension- Converting ... Angiotensin-coverting Enzyme Inhibitors A Process For The Preparation Of Cis, Endo-2- Azabicyclo-(3.3.0)-octane-... Combination Of Angiotensin-converting Enzyme Inhibitors With Calcium Ant... Use Of A Combination Of Angiotensin-converting Enzyme Inhibitor And Calc... Identification Test For Highly Refined Sesame Oil Process Of Preparing Proline Derivatives Cis, Endo-2-azabicyclo-(3.3.0)-octane-3-carboxylic Acids, A Process For ... Usle Of A Combination Of Angiotensin-converting Enzyme Inhibitor And Cal... Method Of Manufacturing A Metal Gasket Optically Active Bicylic Imino-alpha-carboxylic Esters Process For The Preparation Of N-alkylated Dipeptides And Their Esters Compounds Having A Cognition Adjuvant Action, Agents Containing Them, An... Disubstituted Proline Derivatives, Process For The Preparation Of Bicyclic Amino Carboxylic Acids, Intermed... Method For The Treatment Of Atherosclerosis, Thrombosis, And Peripheral ... Cis, Endo-2-azabicycloalkane-3-carboxylic Acid Derivatives Racemates Of Optically Active Bicyclic Imino-alpha- Carboxylic Esters Intermediates For Preparing Mono-,bi-and Tricyclic Amino Acids Process For The Resolution Of Racemates Of Optically Active Bicyclic Imi... Stabilized Polymer Film Coated Compounds And Stabilized Formulations In ... Angiotensin-coverting Enzyme Inhibitors A Process For The Preparation Of Cis, Endo-2- Azabicyclo-(3.3.0)-octane-... Combination Of Angiotensin-converting Enzyme Inhibitors With Calcium Ant... ...and 39 more
	6/22/1998	Credit Suisse First Boston	Assignee	Application Application Application Application Application Patent Patent Patent Patent Patent	06616982 06796467 06024139 06451891 08476490 4933360 4215104 4465660 5656296 4547358	Dual Control Sustained Release Drug Delivery Systems And Methods For Pre... Sustained Release Tablet Containing At Least 95 Percent Theophylline Sustained Release Tablet Containing At Least 95 Percent Theophylline Dual Control Sustained Release Drug Delivery Systems And Methods For Pre... Multi-fractionable Tablet Structure Sustained Release Tablet Containing At Least 95 Percent Theophylline Novel Chlorthalidone Process And Product Multi-fractionable Tablet Structure Sustained Release Tablet Containing At Least 95 Percent Theophylline Novel Chlorthalidone Process And Product
	6/17/1997	Barr, Mark	Assignor	Application Patent	08877752 5811313	Identification Test For Highly Refined Sesame Oil Identification Test For Highly Refined Sesame Oil

38 Rows Total

	Date Recorded	Party	Role	Document Type	Document No.	Image
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Application	85250977
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Application	74131739
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Application	78284102
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Trademark	578347
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Trademark	2031644
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Trademark	3589117
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Application	71638729
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Application	74700377
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Application	78842125
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Trademark	2927079
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Trademark	684353
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Trademark	2871392
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Application	74700382
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Application	72064174
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Application	78144044
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Trademark	3396250
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Trademark	1259079
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Trademark	2874243
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Application	78842009
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Application	73376112
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Application	78144049
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Trademark	0
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Trademark	1912168
	3/11/2013	Kp Pharmaceuticals, LLC	Assignor	Trademark	2865269
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Application	74700382
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Application	72064174
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Application	78144044
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Trademark	3396250
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Trademark	1259079
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Trademark	2874243
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Application	78842009
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Application	73376112
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Application	78144049
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Trademark	0
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Trademark	1912168
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Trademark	2865269
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Application	85250977
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Application	74131739
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Application	78284102
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Trademark	578347
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Trademark	2031644
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Trademark	3589117
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Application	71638729
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Application	74700377
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Application	78842125
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Trademark	2927079
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Trademark	684353
	3/9/2013	Kp Pharmaceuticals, LLC	Assignee	Trademark	2871392
	2/2/2011	Credit Suisse Ag As Successor To Credit ...	Assignor	Trademark	684353
	2/2/2011	Credit Suisse Ag As Successor To Credit ...	Assignor	Application	72064174

494 Rows Total	Page 1 of 10 | Go To

1	501 5th Street Bristol, TX 37620 Get Directions	2	501 5th Street Bristol, TN 37629 Get Directions
3	601 Fifth Street Bristol, TN 37620 Get Directions	4	501 Fifth Avenue Bristol, TN 37620 Get Directions
5	7 ROSZEL RD., 5TH FLOOR PRINCETON, NJ 08540 Get Directions	6	400 Crossing Blvd Bridgewater, NJ 08807 Get Directions
7	501 5th Street Bristol, TN 37620 Get Directions	8	CORPORATE COUNSEL 501 FIFTH STREET BRISTOL, TN 37620 Get Directions
9	Legal Department 501 FIFTH STREET BRISTOL 37620 Get Directions	10	510 5th Street Bristol, TN 37620 Get Directions
11	501 Fifth Street Bristol, TN 37601 Get Directions	12	501 Fifth Street Bristol, TN 37920 Get Directions
13	501 5th Street Bristol, TX 37629 Get Directions

Incoming Payments

This organization has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This organization has not disclosed any outgoing payments to lobbying groups.

Parent Entities

• Interfilm, Inc.
• Novavax, Inc.

Corporate Family (3)

Track Corporate Family

• Interfilm, Inc., None
• Novavax, Inc., None
• Pfizer, Inc., None

Subsidiaries

• Pfizer, Inc.

Sign in to add additional links.